BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16824822)

  • 1. A1c and mortality: an unexpected relationship in patients with advanced heart failure.
    Tayek JA
    Am Heart J; 2006 Jul; 152(1):e5; author reply e7. PubMed ID: 16824822
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
    Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin A1c in diabetes: panacea or pointless?
    Sacks DB
    Diabetes; 2013 Jan; 62(1):41-3. PubMed ID: 23258914
    [No Abstract]   [Full Text] [Related]  

  • 5. ADVANCE and glycaemia thresholds: a need to clarify the statistical approach.
    Currie CJ
    Diabetologia; 2012 Aug; 55(8):2298-9; author reply 2300. PubMed ID: 22610398
    [No Abstract]   [Full Text] [Related]  

  • 6. Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure.
    Berry C; Brett M; Stevenson K; McMurray JJ; Norrie J
    Heart; 2008 Mar; 94(3):296-304. PubMed ID: 17664189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of glycosylated hemoglobin as a prognostic indicator in amputations in the diabetic patient].
    Rodríguez García MA; Fernández Fernández I; Griera Borras JL; Durán García S
    Rev Clin Esp; 1983 Nov; 171(3):179-83. PubMed ID: 6669752
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postprandial hyperglycemia].
    Perusicová J
    Vnitr Lek; 2003 Dec; 49(12):907-10. PubMed ID: 15040153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction.
    Hadjadj S; Coisne D; Mauco G; Ragot S; Duengler F; Sosner P; Torremocha F; Herpin D; Marechaud R
    Diabet Med; 2004 Apr; 21(4):305-10. PubMed ID: 15049930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on: Matsushita et al. (2010) The association of hemoglobin A1c with incident heart failure among people without diabetes: The atherosclerosis risk in communities study. Diabetes;59:2020-2026.
    Oda E
    Diabetes; 2011 Jan; 60(1):e5; author reply e6. PubMed ID: 21193729
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biological surveillance of diabetes mellitus: point of view of the diabetologist].
    Grimaldi A
    Ann Biol Clin (Paris); 1999; 57(4):458-62. PubMed ID: 10432369
    [No Abstract]   [Full Text] [Related]  

  • 12. Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications.
    Hirsch IB; Brownlee M
    JAMA; 2010 Jun; 303(22):2291-2. PubMed ID: 20530784
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance, pathogenesis, and management of postprandial hyperglycemia.
    Gerich JE
    Arch Intern Med; 2003 Jun; 163(11):1306-16. PubMed ID: 12796066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated haemoglobin in the year 2000.
    Kilpatrick ES
    J Clin Pathol; 2000 May; 53(5):335-9. PubMed ID: 10889813
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glycosylated hemoglobin and diabetes mellitus].
    Leutenegger M; Poynard JP; Maquart FX; Borel JP
    Diabete Metab; 1982 Sep; 8(3):249-63. PubMed ID: 7141065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction.
    Britton KA; Aggarwal V; Chen AY; Alexander KP; Amsterdam E; Fraulo E; Muntner P; Thomas L; McGuire DK; Wiviott SD; Roe MT; Schubart UK; Fox CS
    Am Heart J; 2011 Apr; 161(4):657-663.e1. PubMed ID: 21473963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemia and heart failure in diabetes types 1 and 2.
    Opie LH
    Lancet; 2011 Jul; 378(9786):103-4. PubMed ID: 21705067
    [No Abstract]   [Full Text] [Related]  

  • 18. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes.
    Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Taori G; Hegarty C; Bailey M
    Crit Care Med; 2011 Jan; 39(1):105-11. PubMed ID: 20975552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
    Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
    Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemoglobin A lc in diabetes mellitus, with special reference to chronic complications].
    Kammerer L; Pintér E; Szelényi J; Brooser G; Jánossy L; Pogátsa G
    Orv Hetil; 1981 Jun; 122(26):1573-5. PubMed ID: 7290666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.